DNTH
Dianthus Therapeutics, Inc. · Healthcare
EVP, CFO, CBO Ryan Savitz sold $739K of Dianthus Therapeutics, Inc.
Sold$738,844
$89.84Price
8,224Shares
−100%Stake
What DNTH did after the filing
- The stock from Mon, Apr 13 open, $90.00
- −3.5%
- S&P 500, same days
- +10.8%
Measured over 30 trading days, to the May 26 close.
Traded Thu, Apr 9. Filed Fri, Apr 10, 4:52 PM ET, after the close. Returns use the Apr 13 open and the May 26 close. Not investment advice.